Read + Share
Le Berre C, Peyrin-Biroulet L. Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel
Disease: the SPIRIT consensus from the IOIBD. Gastroenterology 2021 Jan 6. pii: S0016-5085(21)00016.
PMID: 33421515
|
 |
|
Le Berre C, Peyrin-Biroulet L. Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel
Disease: the SPIRIT consensus from the IOIBD. Gastroenterology 2021 Jan 6. pii: S0016-5085(21)00016.
PMID: 33421515
|
|
|
|